Organization chart
Governing Council
Executive Committee
Scientific Director
Assistant Directors
Research Ethics Committee
Animal Welfare Organ
External Scientific Committee
Quality Commission
Training Commission
Equality and Diversity Commission
Commission for Humanization and SSR
Internal Scientific Committee
Health and Safety Committee
Technical Secretary
FIBHULP
Company Committee of FIBHULP
Scientific Director
 
José Luis López-Sendón Henstchel 
direccion@idipaz.es
 
Dr. José Luis López-Sendón has a long and distinguished career in health care and research and has made important scientific contributions in the field of cardiology. Born in La Palma, of Galician parentage, he studied Medicine at the University of Valladolid and specialized in Cardiology at the Institute of Cardiology in Madrid. He has been head of the Coronary Unit at La Paz and Gregorio Marañón Hospitals. In the last 15 years he has been head of the Cardiology Service at the Hospital Universitario La Paz, considered among the best cardiologists at international level.
 
At IdiPAZ he has been director of the Clinical and Invasive Cardiology research group and coordinator of the cardiovascular area for the last 10 years. He published his first original article in 1974 and since then his research work has been incessant, with complete dedication to public and academic medicine, resulting in more than 1500 scientific publications (h-Index 83, more than 55,000 citations.
 
He is considered one of the most relevant researchers in the field of Cardiology. His main lines of research include acute and chronic ischemic heart disease, heart failure, and cardiotoxicity. His research method evolved over the years. Initially his research was local, but he soon realized the essential value of international multidisciplinary groups and basic research. As a result, he has participated in the organization of multiple research projects in collaboration with other institutes, including the Universities of Massachusetts, Upsala, New York, Duke, MacMaster and the Montreal Heart Institute, alternating research, management, organization and supervision positions, which has allowed him to establish national and international relationships at the highest level, as evidenced by his participation in the paradigm shift in the diagnosis and treatment of cardiovascular diseases.